. 2007 Jun;14(10):1-3.

Exploring the depression-bone connection. A new study finds that antidepressant use doubles fracture risk. Other research point to links between depression and bone loss

No authors listed

No authors listed. Harv Womens Health Watch. 2007 Jun.

. 2007 Jun;14(10):1-3.

No abstract available

Similar articles

Depression: a major, unrecognized risk factor for osteoporosis?
Cizza G, Ravn P, Chrousos GP, Gold PW. Cizza G, et al. Trends Endocrinol Metab. 2001 Jul;12(5):198-203. doi: 10.1016/s1043-2760(01)00407-6. Trends Endocrinol Metab. 2001. PMID: 11397644 Review.
Antidepressant medications and osteoporosis.
Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyère O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P. Rizzoli R, et al. Bone. 2012 Sep;51(3):606-13. doi: 10.1016/j.bone.2012.05.018. Epub 2012 May 30. Bone. 2012. PMID: 22659406 Review.
Fracture risks of antidepressants.
Vestergaard P. Vestergaard P. Expert Rev Neurother. 2009 Jan;9(1):137-41. doi: 10.1586/14737175.9.1.137. Expert Rev Neurother. 2009. PMID: 19102674
The "depressive" face of osteoporosis and the "osteoporotic" face of depression.
Aloumanis K, Mavroudis K. Aloumanis K, et al. Hormones (Athens). 2013 Jul-Sep;12(3):350-62. doi: 10.1007/BF03401301. Hormones (Athens). 2013. PMID: 24121377 Review.
Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
Perreault S, Dragomir A, Blais L, Moride Y, Rossignol M, Ste-Marie LG, Fernandès JC. Perreault S, et al. Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):248-59. doi: 10.1002/pds.1551. Pharmacoepidemiol Drug Saf. 2008. PMID: 18213734